IHPI Ibogaine Healthcare Policy Institute Donate

Ibogaine Healthcare Policy Institute

Policy infrastructure for regulated ibogaine care.

IHPI is a credible, neutral resource helping healthcare decision-makers evaluate ibogaine therapy with safety, payment, and implementation discipline.

We are building the legal and operational infrastructure to bring regulated ibogaine treatment into the U.S. to help veterans and millions of others living with PTSD and opioid use disorder.

Why now

The gap is not interest. It is decision-maker uncertainty.

CMS, Medicaid leaders, commercial payers, regulators, and health system executives need decision-grade health economics, reimbursement mechanics, operational delivery models, and safety standardization.

Without neutral technical infrastructure, fragmented or self-interested narratives fill the space. That increases perceived risk and slows legitimate evaluation.

IHPI translates uncertainty into public goods that institutions can use inside real workflows: actuarial memos, benefit design sessions, coverage criteria drafts, and implementation planning.

48.5M

Americans had a substance use disorder in the past year.

70k+

Americans died from drug overdoses last year.

$1.5T

Annual economic burden on the U.S. healthcare system.

What IHPI builds

Healthcare adopts what it can define, code, reimburse, and monitor.

01

Regulatory pathways

State playbooks and policy scaffolds that help regulators move from interest to approved evaluation pathways.

02

Safety and delivery standards

Screening, monitoring, site-of-care, and quality guardrails that make evaluation insurable and scalable.

03

Payer system infrastructure

Payer-ready economics, coding roadmaps, budget impact logic, and coverage criteria scaffolds.

Latest publications

Analysis for the implementation window.

Policy Explainer April 2026

What the Federal Psychedelics Executive Order actually does, and does not do.

The order accelerates federal posture around psychedelic medicine, but the work that determines patient access still sits downstream: agency follow-through, supply, safety, coverage, and delivery infrastructure.

Read the explainer

Neutral technical infrastructure

The field needs a policy voice institutions can use.

Contact IHPI